These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. President's Message: contrast echocardiography: moving from controversy to consensus. Zoghbi WA J Am Soc Echocardiogr; 2008 Sep; 21(9):A25-6. PubMed ID: 18765170 [No Abstract] [Full Text] [Related]
5. Safety and usefulness of transesophageal echocardiography in persons aged greater than or equal to 70 years. Ofili EO; Rich MW Am J Cardiol; 1990 Nov; 66(17):1279-80. PubMed ID: 2239741 [No Abstract] [Full Text] [Related]
6. Contrast echocardiography: beyond a black box warning? Lester SJ; Miller FA; Khandheria BK J Am Soc Echocardiogr; 2008 May; 21(5):417-8. PubMed ID: 18456157 [No Abstract] [Full Text] [Related]
7. Saline Contrast Echocardiography in the Era of Multimodality Imaging--Importance of "Bubbling It Right". Gupta SK; Shetkar SS; Ramakrishnan S; Kothari SS Echocardiography; 2015 Nov; 32(11):1707-19. PubMed ID: 26257397 [TBL] [Abstract][Full Text] [Related]
8. Transesophageal echocardiography in the intensive care patient. Porembka DT; Hoit BD Crit Care Med; 1991 Jun; 19(6):826-35. PubMed ID: 2055062 [No Abstract] [Full Text] [Related]
9. Repetitive loss of consciousness during echocardiography. Meurin P; Renaud N; Jault F; Pavie A Int J Cardiol; 1999 Dec; 72(1):91-2. PubMed ID: 10636639 [No Abstract] [Full Text] [Related]
10. Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction? Van Camp G; Droogmans S; Cosyns B Eur Heart J; 2007 May; 28(10):1190-2. PubMed ID: 17470674 [No Abstract] [Full Text] [Related]
11. The use of transesophageal echocardiography in detecting aortic atherosclerosis in patients with embolic disease. Simons AJ; Carlson R; Hare CL; Obeid AI; Smulyan H Am Heart J; 1992 Jan; 123(1):224-6. PubMed ID: 1729832 [No Abstract] [Full Text] [Related]
15. A review of the safety and clinical utility of contrast echocardiography. Chai SC; Tan PJ; Tong KL Singapore Med J; 2020 Apr; 61(4):181-183. PubMed ID: 31820006 [TBL] [Abstract][Full Text] [Related]
16. Old wine in new bottle: utility of contrast-enhanced point-of-care echocardiogram in the ED. Zhang S; Zhu D; Zhi W; Cao Y Am J Emerg Med; 2013 Aug; 31(8):1288-9. PubMed ID: 23810073 [No Abstract] [Full Text] [Related]
17. Contrast agents for echocardiographic studies within 24 h after myocardial infarction. Becher H Eur J Echocardiogr; 2008 Nov; 9(6):719-20. PubMed ID: 18772218 [No Abstract] [Full Text] [Related]
18. Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. Kaya MG; Akpek M; Elcik D; Kalay N; Yarlioglues M; Koc F; Dogdu O; Sahin O; Ardic I; Oguzhan A; Ergin A Am J Cardiol; 2012 Mar; 109(6):851-5. PubMed ID: 22189011 [TBL] [Abstract][Full Text] [Related]
19. Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration). Grayburn PA Am J Cardiol; 2008 Mar; 101(6):892-3. PubMed ID: 18328861 [No Abstract] [Full Text] [Related]
20. Evaluating the potential risks of bubble studies during echocardiography. Bassett GC; Lin JW; Tran MM; Sistino JJ Perfusion; 2015 Apr; 30(3):219-23. PubMed ID: 24947456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]